Northstar Group, Inc. Bristol Myers Squibb CO Transaction History

Northstar Group, Inc.

$570 Million
Q3 2024

A detailed history of Northstar Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Northstar Group, Inc. holds 5,824 shares of BMY stock, worth $336,394. This represents 0.05% of its overall portfolio holdings.

Number of Shares

5,824

Previous 5,638 3.3%

Holding current value

$336,394

Previous $234,000 28.63%

% of portfolio

0.05%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$39.66 - $51.75 $7,376 - $9,625	186 Added 3.3%	5,824 $301,000
Q2 2024 Jul 17, 2024	BUY	$40.25 - $52.99 $6,721 - $8,849	167 Added 3.05%	5,638 $234,000
Q1 2024 Apr 17, 2024	SELL	$47.98 - $54.4 $4,798 - $5,440	-100 Reduced 1.8%	5,471 $296,000
Q4 2023 Jan 10, 2024	SELL	$48.48 - $57.85 $56,673 - $67,626	-1,169 Reduced 17.34%	5,571 $285,000
Q3 2023 Oct 19, 2023	SELL	$57.89 - $64.73 $78,151 - $87,385	-1,350 Reduced 16.69%	6,740 $391,000
Q1 2023 Apr 27, 2023	SELL	$65.71 - $74.53 $8,279 - $9,390	-126 Reduced 1.53%	8,090 $560,000
Q3 2022 Oct 26, 2022	BUY	$0.13 - $76.84 $13 - $7,684	100 Added 1.23%	8,216 $584,000
Q1 2022 May 05, 2022	SELL	$61.48 - $73.72 $18,444 - $22,116	-300 Reduced 3.56%	8,116 $593,000
Q3 2021 Nov 02, 2021	SELL	$59.17 - $69.31 $8,875 - $10,396	-150 Reduced 1.75%	8,416 $498,000
Q2 2021 Jul 28, 2021	BUY	$61.91 - $67.42 $51,075 - $55,621	825 Added 10.66%	8,566 $572,000
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $50,439 - $56,728	-850 Reduced 9.89%	7,741 $489,000
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $92,384 - $104,688	1,600 Added 22.89%	8,591 $532,000
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $8,614 - $9,546	-150 Reduced 2.1%	6,991 $422,000
Q1 2020 May 04, 2020	SELL	$46.4 - $67.43 $3,480 - $5,057	-75 Reduced 1.04%	7,141 $398,000
Q4 2019 Jan 21, 2020	BUY	$49.21 - $64.19 $14,074 - $18,358	286 Added 4.13%	7,216 $463,000
Q3 2019 Nov 01, 2019	SELL	$42.77 - $50.71 $33,788 - $40,060	-790 Reduced 10.23%	6,930 $351,000
Q2 2019 Jul 12, 2019	SELL	$44.62 - $49.34 $92,408 - $102,183	-2,071 Reduced 21.15%	7,720 $350,000
Q1 2019 Apr 16, 2019	BUY	$45.12 - $53.8 $55,136 - $65,743	1,222 Added 14.26%	9,791 $467,000
Q4 2018 Jan 22, 2019	SELL	$48.76 - $63.23 $21,893 - $28,390	-449 Reduced 4.98%	8,569 $445,000
Q3 2018 Oct 26, 2018	BUY	$55.19 - $62.25 $55 - $62	1 Added 0.01%	9,018 $560,000
Q2 2018 Jul 27, 2018	SELL	$50.53 - $62.98 $11,369 - $14,170	-225 Reduced 2.43%	9,017 $499,000
Q1 2018 Apr 13, 2018	BUY	$59.92 - $68.98 $98,927 - $113,885	1,651 Added 21.75%	9,242 $585,000
Q4 2017 Jan 23, 2018	BUY	$59.94 - $65.35 $2,997 - $3,267	50 Added 0.66%	7,591 $465,000
Q3 2017 Oct 16, 2017	BUY	$55.23 - $63.74 $416,489 - $480,663	7,541	7,541 $481,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northstar Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Northstar Group, Inc. with notifications on news.

Account

Northstar Group, Inc. Bristol Myers Squibb CO Transaction History